Summit Therapeutics Warns Cash Reserves May Not Sustain Operations Beyond a Year
Summit Therapeutics (SMMT) disclosed that its current cash and short-term investments may not be sufficient to fund operations for at least the next twelve months. The announcement led to a ~5% drop in after-hours trading.
Tickers: $SMMT
Topics: cash runway stock price movement